Skip to content

NOVELTY-CT sub-study Observational study to evaluate associations between CT features and patients characteristics of obstructive respiratory diseases (Asthma and/or COPD) in the Japanese subjects recruited in the NOVELTY

NOVELTY-CT sub-study Observational study to evaluate associations between CT features and patients characteristics of obstructive respiratory diseases (Asthma and/or COPD) in the Japanese subjects recruited in the NOVELTY - NOVELTY-CT sub-study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1030230001
Enrollment
300
Registered
2023-04-02
Start date
2023-03-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma and/or COPD

Interventions

None listed

Sponsors

Kawano Yoshiaki
Lead Sponsor
AstraZeneca
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Enrolled in the main NOVELTY study from Japan study sites 2. Have available clinical data NOVELTY study database (ie patients must be included in the analysis set) 3. Able to sign written, informed consent (or having a responsible, legally authorized representative acting on patients behalf) 4. Have available chest CT image at baseline (within 1 year before the date of at least one visit of NOVELTY study)

Exclusion criteria

Exclusion criteria: No exclusion criterion in this study

Design outcomes

Primary

MeasureTime frame
Baseline demographic and clinical characteristics for +/- emphysema patients.

Secondary

MeasureTime frame
Changes during 3 yearly follow-up in key clinical characteristics for +/- emphysema patients

Contacts

Public ContactNoriyuki Ishikawa

Medical, Evidence & Observational Research

noriyuki.ishikawa@astrazeneca.com+81-3-3457-9300

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026